로딩 중…
지수 로딩 중…
DAEWOONG CO.,LTD
003090· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩17,570-2.23%
2026-06-19
Price Chart
DAEWOONG CO.,LTD-27.25%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 1.02T KRW |
| Revenue | 2.08T KRW |
| Net Income | 202.16B KRW |
| Total Assets | 3.41T KRW |
| Net Assets | 1.85T KRW |
| Employees | 349 |
| Value | |
| P/E | 5.05x |
| P/B | 0.55x |
| PEG | 0.05x |
| P/S | 0.49x |
| EV/EBITDA | 90.15x |
| FCF Yield | -3.64% |
| Profitability | |
| ROE | 10.91% |
| ROA | 5.93% |
| Op. Margin | 11.95% |
| Revenue Growth | 2.34% |
| Earnings Growth | 103.57% |
| Financial Health | |
| Debt Ratio | 183.90% |
| Total Debt | 1.17T KRW |
| FCF | -37.22B KRW |
| Cash | 259.69B KRW |
| Current Ratio | 1.20x |
| Net Debt/EBITDA | 42.47x |
| Dividend | |
| Div. Yield | 1.11% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -27.25% |
| 1M Return | -10.81% |
| From 52W High | -42.58% |
| 1Y MDD | -43.41% |
| Trading | |
| Volume | 54,343 shares |
| Foreign Own. | 4.98% |
| Per Share | |
| EPS | 3,167 KRW |
| BPS | 30,030 KRW |
Company Info
Daewoong, established in 1961 as Daehan Vitamin Industry Co., Ltd. and listed in 1973, transitioned to a holding company through a spin-off in 2002. As the holding company of a global healthcare group, it owns 36 subsidiaries including Daewoong Pharmaceutical, engaging in pharmaceutical manufacturing and investment. Daewoong focuses on enhancing global market penetration with Fexuclue, Enavlo, and Nabota, while strengthening K-Bio's status. The company is headquartered in Seongnam, Gyeonggi Province.